国际医学：2025年上半年，公司实现营业收入203430.77万元

Core Viewpoint - The company anticipates a revenue decline of 15.95% year-on-year, amounting to 203.43 million yuan in the first half of 2025 due to ongoing reforms in medical insurance payment policies [2] Group 1: Company Performance - In the second quarter of 2025, the company's medical institutions are gradually adapting to the DRG payment reform, leading to an improvement in operations [2] - The company emphasizes a strategy focused on solid management practices, cost control, and efficiency enhancement to navigate industry changes [2] Group 2: Strategic Focus - The company aims to build competitive advantages through differentiated strategies and enhance service value to adapt to industry transformations [2]